Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04280848
Title Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma (UCPVax-Glio)
Acronym UCPVax-Glio
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Besançon Besançon France Details
CHU Bordeaux Bordeaux France Details
Centre Georges François Leclerc Dijon France Details
CHU La Timone Marseille France Details
Hôpital Saint-Louis Paris France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field